Nitya Batra

and 5 more

IntroductionPulmonary sclerosing pneumocytoma is a rare group of benign pulmonary neoplasms that usually affects older adults over 50 years of age [1].  This neoplasm is more commonly seen in women, with female to male ratio of 5:1 and is predominantly seen in Asian ethnicities [2]. These tumors originate from type II alveolar pneumocytes and are hence classified as adenoma under the 2021 World Health Organization (WHO) classification of tumors [3]. They account for 3-5 percent of total benign lung tumors [4].One of the striking aspects of PSP is its clinical presentation, or rather the lack thereof in many cases. It is often discovered incidentally during routine chest imaging, such as chest X-rays or CT scans, due to its asymptomatic nature. However, when symptoms do occur, they tend to be non-specific, including cough, chest pain, or respiratory distress. This variability in clinical manifestation further complicates the diagnosis of PSP, as these symptoms overlap with those of other pulmonary conditions. Moreover, it is essential to consider the potential for malignant transformation, as a subset of PSP cases have exhibited aggressive behavior [5].Herein, we describe a case of a 73-year-old female who was found to have an incidental lung nodule. In view of the history of interval increase in the size of the lung nodule, the patient underwent a CT-guided lung biopsy, which was characterized as sclerosing pneumocytoma, and the patient was referred to thoracic surgery for subsegmental right middle lobe resection.